New York, NY -- (SBWIRE) -- 01/11/2013 -- Arena Pharmaceuticals Inc. (NASDAQ: ARNA), a clinical-stage biopharmaceutical company engaged in the discovery, development and commercialization of oral drugs that target G protein-coupled receptors, is marginally higher in mid-day trading today, reversing some of the losses from the previous two trading sessions.
At last check, ARNA was trading 0.43% higher at $9.74 on volume of 3.92 million, which is nearly half of the daily average volume of 8.14 million. The stock is down nearly 3.5% in the last three trading sessions. ARNA has been facing stiff resistance at $10. A strong bullish trend will be established if the stock can break through this level.
Find out what traders and investors need to do with ARNA by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=ARNA
LDK Solar Co. Ltd. (ADR) (NYSE: LDK), a China-based vertically integrated manufacturer of photovoltaic (PV) products, is up sharply in mid-day trading today, continuing its excellent run from recent weeks. LDK is currently trading 1.83% higher at $2.22 on volume of 962,914, which is nearly a third of the daily average volume of 3.02 million.
LDK has gained more than 7% in the last three trading sessions. The stock has been gaining momentum this week after the Chinese government announced plans to increase solar installations in 2013. Earlier this week, LDK also announced that it regained compliance with New York Stock Exchange’s (NYSE) continued listing requirement.
Find out if LDK could maintain its momentum in the upcoming trading sessions by getting the free full report here: http://www.wallstreetreport.net/market-scan/?symbol=LDK
WallStreetReport.net issues momentum alerts on stocks that can provide gains to day traders. WallStreetReport.net provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. WallStreetReport.net monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals WallStreetReport.net is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the WallStreetReport.net newsletter and receiving alerts from a Pro-Active team of researchers. Wall Street Report believes traders should have a chance at successfully trading Penny Stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.WallStreetReport.net
Disclosure: WallStreetReport.net is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit WallStreetreport.Net website, for complete risks and disclosures.
BlueLys, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
WALL STREET REPORT